IGM Biosciences Inc: Patents

View up-to-date information on IGM Biosciences Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
WO2022177870A1	Application	MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF	A61K2039/505; A61K2039/543; A61K2039/544; A61P31/14; C07K16/10; C07K2317/21; C07K2317/31; C07K2317/33; C07K2317/35; C07K2317/52; C07K2317/53; C07K2317/565; C07K2317/76; C07K2317/92	August 25, 2022
WO2022178047A1	Application	ANTI-CD123 BINDING MOLECULES AND USES THEREOF		August 25, 2022
US20220267415A1	Application	MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF	A61K2039/505; A61P31/14; C07K16/10; C07K2317/31; C07K2317/35	August 25, 2022
EP3870223A4	Search Report	MULTIVALENTE IGM- UND IGA-FC-BASIERTE BINDUNGSMOLEKÜLE	A61K2039/505; A61P37/06; C07K14/705; C07K14/70503; C07K14/70521; C07K14/70532; C07K14/70578; C07K16/00; C07K16/2803; C07K16/2818; C07K16/2827; C07K16/2863; C07K2317/31; C07K2317/52; C07K2317/528; C07K2317/622; C07K2317/734; C07K2319/00; C07K2319/30; C12N15/62; C12N15/85; C12N2510/00; C12N5/0636	August 24, 2022
US11401337B2	Grant	Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function	C07K16/2809; C07K16/2887; C07K2317/31; C07K2317/526; C07K2317/622; C07K2317/71; C07K2317/734	August 02, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer